Compare GDDY & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDDY | ALGN |
|---|---|---|
| Founded | 1997 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 12.7B |
| IPO Year | 2014 | 2000 |
| Metric | GDDY | ALGN |
|---|---|---|
| Price | $100.49 | $160.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 12 |
| Target Price | $136.44 | ★ $199.82 |
| AVG Volume (30 Days) | ★ 2.2M | 890.8K |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 0.53 |
| EPS | ★ 3.43 | 3.09 |
| Revenue | N/A | ★ $387,126,000.00 |
| Revenue This Year | $7.94 | $5.78 |
| Revenue Next Year | $6.10 | $4.62 |
| P/E Ratio | ★ $28.30 | $52.43 |
| Revenue Growth | N/A | ★ 23.95 |
| 52 Week Low | $71.59 | $122.00 |
| 52 Week High | $148.51 | $200.44 |
| Indicator | GDDY | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 59.03 | 38.64 |
| Support Level | $81.16 | $153.68 |
| Resistance Level | $106.00 | $180.57 |
| Average True Range (ATR) | 3.86 | 6.14 |
| MACD | 0.48 | -1.52 |
| Stochastic Oscillator | 90.43 | 11.24 |
GoDaddy Inc provides digital solutions and services for entrepreneurs, small businesses, individuals, organizations, developers, designers, and domain investors. It offers tools intended to support business creation and management through an integrated service platform. The company operates through two segments: Applications and Commerce (A&C) and Core Platform (Core). The majority of the company's revenue is derived from the Core Platform segment, which consists of sales of domain registrations and renewals, aftermarket domain sales, website hosting products and website security products. Geographically, it generates the maximum revenue from the United States.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.